Kala-azar, also known as visceral leishmaniasis (VL), is a disease caused by Leishmania
infantum and L. donovani. Patients experience symptoms such as fever, weight loss …

Background The timely identification of visceral leishmaniasis (VL) patients with a higher risk
of death is essential for meeting the target of reducing case-fatality rates in the Americas …

Background Visceral leishmaniasis (VL) is one of the major public health burden, mainly
distributed throughout tropical and subtropical regions of the world. Among the Sub-Saharan …

Objectives Visceral leishmaniasis (VL) is a public health threat for several tropical countries,
including Brazil. Therapy failures and relapses aggravate VL morbidity and mortality. Our …

OASS is a specific enzyme that helps Leishmania parasite to survive the oxidative stress
condition in human macrophages. SAT C-terminal peptides in several organisms, including …

Ethiopia is among the countries with a high leishmaniasis burden. In this retrospective
review, we aimed to determine hematological and clinical features associated with initial …

Background: Over the last decade, a few cases of visceral leishmaniasis (VL) have been
reported in some provinces of northeastern Iran. We aimed to investigate clinical and …

Background: The long-term effects of schistosomiasis on the glomerulus may contribute to
the development of chronic kidney disease. This study aimed to investigate baseline …

Protozoa are parasitic organisms that are among the most important pathogens worldwide.
They are classified into four groups and in infected persons, the disease process may be …

Background: The long-term effects of schistosomiasis on the glomerulus may contribute to
the development of chronic kidney disease. This study aimed to investigate baseline …